Deciphera Pharma Appoints Stephen Ruddy Chief Technical Officer

Xconomy Boston — 

Stephen Ruddy has been appointed chief technical officer of Waltham, MA-based Deciphera Pharmaceuticals (NASDAQ: DCPH). Before joining Deciphera, Ruddy was vice president of pharmaceutical development at Tesaro (NASDAQ: TSRO), also based in Waltham. Last year, Deciphera raised $128 million in an IPO to finance clinical testing of its cancer drug DCC-2618 in patients who have tumors in the gastrointestinal tract.